Granja Clarissa, Moliterno Ricardo A, Ferreira Mônica S, Fonseca João A, Kalil Jorge, Coelho Verônica
Heart Institute, University of São Paulo Medical School, São Paulo, SP, Brazil.
Hum Immunol. 2004 Feb;65(2):124-34. doi: 10.1016/j.humimm.2003.10.007.
Heat shock proteins (Hsp) are moving from the category of basically intracellular chaperone molecules to important proteins in both innate and acquired immune responses, with great potential for clinical application as immunomodulators. Both proinflammatory and regulatory Hsp-reactive T cells have been described in animal models of autoimmune diseases. To investigate the role of autoreactivity to Hsp60 and Hsp70 in human transplantation, we analyzed, sequentially, peripheral blood mononuclear cell proliferation and cytokine production before and at different time points after renal transplantation, as well as the modulation of proliferation to Hsp in the presence of exogenous cytokines. Proliferation to Hsp60 and Hsp70 in the pretransplantation (pre-Tx) period was significantly associated with rejection episodes in the first months post-Tx. In contrast, IL-4 production was significantly associated with absence of rejection. Addition of exogenous IL-4 distinctly modulated the proliferative response to Hsp60; inhibiting proliferation in 83% of patients in the early post-Tx period (0-6 months), in which rejection episodes occurred, and inducing proliferation in 62.5% of patients in the later period (>12-24 months), when no rejection was observed. Characterization of autoreactive anti-Hsp60 regulatory T cells may permit new approaches to control the proinflammatory response to the graft, as well as aggressive autoimmunity.
热休克蛋白(Hsp)正从基本属于细胞内伴侣分子的范畴,转变为先天性和获得性免疫反应中的重要蛋白质,作为免疫调节剂具有巨大的临床应用潜力。在自身免疫性疾病的动物模型中,已描述了促炎性和调节性Hsp反应性T细胞。为了研究对Hsp60和Hsp70自身反应性在人类移植中的作用,我们依次分析了肾移植前及移植后不同时间点外周血单个核细胞的增殖和细胞因子产生情况,以及在外源性细胞因子存在下对Hsp增殖的调节。移植前(Tx前)阶段对Hsp60和Hsp70的增殖与移植后最初几个月的排斥反应显著相关。相反,IL-4的产生与无排斥反应显著相关。添加外源性IL-4明显调节了对Hsp60的增殖反应;在移植后早期(0 - 6个月)发生排斥反应的患者中,83%的患者增殖受到抑制,而在后期(>12 - 24个月)未观察到排斥反应的患者中,62.5%的患者增殖受到诱导。对自身反应性抗Hsp60调节性T细胞的特征描述可能会带来控制对移植物的促炎反应以及侵袭性自身免疫的新方法。